Science Explorer Interactive view Map
Company · Guangzhou · China

RayBiotech (China)

raybiotech.comROR OpenAlex
Research works
35
▼ 4% vs 2013–17
Citations
692
19.5 per fractional work
Top-10% rate
15.9%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: RayBiotech (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.24× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.33× its world share, 0 worksImmunology and Micro…Neuroscience: 1.16× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.96× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.94× its world share, 0 worksChemistryComputer Science: 0.27× its world share, 0 worksComputer ScienceEngineering: 0.61× its world share, 1 worksEngineeringEnvironmental Science: 0.35× its world share, 0 worksEnvironmental ScienceMedicine: 2.70× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.0×. Every wedge is a field page.

Who are the top researchers at RayBiotech (China)?

Ranked on the composite score, Ruo‐Pan Huang lead among researchers whose main affiliation is RayBiotech (China).

  1. 1 Ruo‐Pan Huang China · #639,848 worldwide 60 citations · 18 works
All ranked researchers at RayBiotech (China)

Which keywords describe research at RayBiotech (China)?

By fractional works in all years, weighted toward what it does more of than the world: High-Throughput Analysis, Protein Microarrays, Glycosylation, Epidemiology, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Epidemiology4▲ 3.0×19 topics
  2. High-Throughput Analysis3▲ 201×1 topic
  3. Protein Microarrays3▲ 464×1 topic
  4. Glycosylation3▲ 42×3 topics
  5. Monoclonal Antibodies3▲ 52×3 topics
  6. Therapeutic Antibodies3▲ 57×2 topics
  7. Antibody Engineering2▲ 71×1 topic
  8. Fc Receptors2▲ 71×1 topic
  9. Inflammation2▲ 3.0×15 topics
  10. Angiogenesis2▲ 12×9 topics
  11. Cancer2▲ 3.5×10 topics
  12. Gut Microbiota2▲ 15×5 topics
  13. Probiotics2▲ 21×4 topics
  14. Vaccine2▲ 12×5 topics
  15. Biosensors2▲ 7.9×3 topics
  16. Pathogenesis2▲ 7.9×6 topics
  17. Aquaculture1▲ 15×3 topics
  18. Immune Response1▲ 6.5×8 topics
  19. Innate Immunity1▲ 11×4 topics
  20. Nanoparticles1▲ 3.0×4 topics
  21. Biomedical Applications1▲ 3.5×2 topics
  22. Molecular Structure1▲ 31×2 topics
  23. Antioxidant Activity1▲ 5.7×4 topics
  24. Electrochemistry1▲ 15×2 topics
  25. Microfluidic Devices1▲ 34×2 topics
  26. Pandemic1▲ 6.5×3 topics

Which research topics does RayBiotech (China) publish most on?

By volume in 2022–2025: Advanced Biosensing Techniques and Applications, SARS-CoV-2 and COVID-19 Research, Cancer Cells and Metastasis and Liver Disease Diagnosis and Treatment.

Advanced Biosensing Tech…0Advanced Biosensing Techniques and Applications: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksCancer Cells and Metasta…0Cancer Cells and Metastasis: 0 fractional worksLiver Disease Diagnosis …0Liver Disease Diagnosis and Treatment: 0 fractional worksElectrochemical sensors and biosensors: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksClusterin in disease pathology: 0 fractional worksInfluenza Virus Research…0Influenza Virus Research Studies: 0 fractional works
Molecular BiologyInfectious DiseasesOncologyEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Cancer Cells and Metastasis Oncology 0 works
  4. 4 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  5. 5 Electrochemical sensors and biosensors Electrical and Electronic Engineering 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 RNA modifications and cancer Molecular Biology 0 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Clusterin in disease pathology Oncology 0 works
  10. 10 Influenza Virus Research Studies Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.4%not open63.6%

World: 28% of research is openly available.

with international co-authors50.6%domestic only49.4%

World: 19% is written across borders.

How has RayBiotech (China)'s research output changed?

Output in 2018–2022 was 4% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Guangzhou

All research institutions in Guangzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.